How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

January 10, 2025

Arcturus Launches H5N1 Vaccine Trial as Cases Rise in US

Human cases in the US. Image credits: CDC Arcturus Therapeutics has initiated a Phase 1

January 10, 2025 No Comments

Monoclonal Antibody Demonstrates Activity Against Dominant COVID-19 Variant

Invivyd’s Chief Scientific Officer Robert Allen, PhDImage credit: Invivyd Waltham, Mass.-based biopharmaceutical company, Inviyd, announced

January 10, 2025 No Comments

Feeding your good gut bacteria through fiber in diet may boost body against infections

The group of bacteria called Enterobacteriaceae, including Klebsiella pneumoniae, Shigella, E.coli and others, is present

January 10, 2025 No Comments

T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development

Scientists from Duke-NUS Medical School and the Singapore General Hospital have discovered that T cells

January 10, 2025 No Comments

Fighting C difficile Before It Starts: Lopoxy Therapeutics Approach

LPOXY Therapeutics, Inc has acquired assets from Xeno Biosciences Inc. to advance its therapy SIDIPREV

January 10, 2025 No Comments

Communicable disease threats report, 4-10 January 2025, week 2

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 –

January 10, 2025 No Comments

Communicable disease threats report, 4-10 January 2025, week 1

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 –

January 10, 2025 No Comments

I’m Sorry, but It’s Time We Talk About Politics

Image credit: Markus Spiske, Pexels It’s trite to say elections have consequences, but those consequences

January 10, 2025 No Comments

Early Release – Respiratory Shedding of Infectious SARS-CoV-2 Omicron XBB.1.41.1 Lineage among Captive White-Tailed Deer, Texas, USA – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

January 10, 2025 No Comments

Early Release – Prions in Muscles of Cervids with Chronic Wasting Disease, Norway – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

January 10, 2025 No Comments

Arcturus Launches H5N1 Vaccine Trial as Cases Rise in US

Monoclonal Antibody Demonstrates Activity Against Dominant COVID-19 Variant

Feeding your good gut bacteria through fiber in diet may boost body against infections

T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development

Fighting C difficile Before It Starts: Lopoxy Therapeutics Approach

Communicable disease threats report, 4-10 January 2025, week 2

Communicable disease threats report, 4-10 January 2025, week 1

I’m Sorry, but It’s Time We Talk About Politics

Early Release – Respiratory Shedding of Infectious SARS-CoV-2 Omicron XBB.1.41.1 Lineage among Captive White-Tailed Deer, Texas, USA – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Early Release – Prions in Muscles of Cervids with Chronic Wasting Disease, Norway – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us